Published in Immunol Rev on January 01, 1979
Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression. Mol Cell Biol (1986) 7.06
Protein tyrosine phosphorylation is induced in murine B lymphocytes in response to stimulation with anti-immunoglobulin. EMBO J (1990) 2.50
Cell growth cycle block of T cell hybridomas upon activation with antigen. J Exp Med (1987) 2.30
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood (2005) 1.96
Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma. Proc Natl Acad Sci U S A (1984) 1.76
Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation. EMBO J (1985) 1.72
Lymphoid precursor cells adhere to two different sites on fibronectin. J Cell Biol (1987) 1.66
Association between B-lymphocyte membrane immunoglobulin and multiple members of the Src family of protein tyrosine kinases. Mol Cell Biol (1992) 1.66
Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med (1995) 1.35
Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc Natl Acad Sci U S A (1988) 1.33
Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J Exp Med (1986) 1.33
Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells. Mol Cell Biol (1986) 1.32
Retroviral expression of alternatively spliced forms of rat fibronectin. J Cell Biol (1990) 1.26
Myristoylation and the post-translational acquisition of hydrophobicity by the membrane immunoglobulin heavy-chain polypeptide in B lymphocytes. Proc Natl Acad Sci U S A (1987) 1.17
Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol Cell Biol (1996) 1.15
Human myeloma cells acquire resistance to difluoromethylornithine by amplification of ornithine decarboxylase gene. Biochem J (1987) 1.01
Immunopathology of natural and experimental lymphomas induced by wild mouse leukemia virus. Am J Pathol (1981) 0.95
Characterization of difluoromethylornithine-resistant mouse and human tumour cell lines. Biochem J (1989) 0.95
Antigen receptor-induced cell cycle arrest in WEHI-231 B lymphoma cells depends on the duration of signaling before the G1 phase restriction point. Mol Cell Biol (1990) 0.93
Levels of ornithine decarboxylase genomic sequences, heterogeneous nuclear RNA and mRNA in human myeloma cells resistant to alpha-difluoromethylornithine. Biochem J (1991) 0.92
Tumor promoter phorbol myristic acetate stimulates immunoglobulin secretion correlated with growth cessation in human B lymphocyte cell lines. J Clin Invest (1981) 0.85
Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells. J Exp Med (1998) 0.84
A major myristylated substrate of protein kinase C and protein kinase C itself are differentially regulated during murine B- and T-lymphocyte development and activation. Mol Cell Biol (1989) 0.81
Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus. J Clin Invest (1985) 0.80
Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation. Cell Mol Immunol (2013) 0.78
Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. J Immunol (1975) 7.00
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell (1991) 6.49
Functional macrophage cell lines transformed by Abelson leukemia virus. Cell (1978) 5.76
Murine B cell leukemia line with inducible surface immunoglobulin expression. J Immunol (1978) 4.93
Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol (1985) 3.62
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature (1975) 3.43
Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature (1987) 3.37
Lipopolysaccharides inhibit lymphosarcoma cells of bone marrow orgin. Nature (1974) 3.15
Polyribosomes of growing bacteria. Science (1967) 2.82
Differences in the surface proteins of mouse B and T cells. Proc Natl Acad Sci U S A (1975) 2.78
Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J Immunol (1977) 2.67
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia (2001) 2.30
Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol (1986) 2.04
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer (1976) 1.97
Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol (1991) 1.92
The role of humoral factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens. J Immunol (1973) 1.90
Growth of B-lymphocytes clones in semisolid culture is mitogen dependent. J Exp Med (1976) 1.86
Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A (1990) 1.86
Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J Immunol (1991) 1.71
Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol Cell Biol (1987) 1.71
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc Natl Acad Sci U S A (1979) 1.63
Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol (1991) 1.62
Lymphosarcoma cell growth is selectively inhibited by B lymphocyte mitogens: LPS, dextran sulfate and PPD. Biochem Biophys Res Commun (1974) 1.60
Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci U S A (1982) 1.60
Retention of lymphocyte characteristics by myelomas and theta + -lymphomas: sensitivity to cortisol and phytohemagglutinin. J Immunol (1973) 1.56
Cell-specific antigens and immunoglobulin synthesis of murine myeloma cells and their variants. J Natl Cancer Inst (1972) 1.55
Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2. J Immunol (1984) 1.54
Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture. Cancer Res (1977) 1.53
Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester. Cell Immunol (1982) 1.44
Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency. J Clin Immunol (1984) 1.44
Induction of human immunoglobulin secretion. I. Synergistic effect of B cell mitogen Cowan I plus T cell mitogens or factors. J Immunol (1981) 1.43
Inducible production of human macrophage growth factor, CSF-1. Blood (1986) 1.40
Leukemia viruses associated with mouse myeloma cells. Proc Natl Acad Sci U S A (1970) 1.40
All classes of murine IgG antibody mediate macrophage phagocytosis and lysis of erythrocytes. J Immunol (1980) 1.29
Expression and induction in vitro of macrophage differentiation antigens on murine cell lines. J Immunol (1983) 1.29
Macrophage factor controlling differentiation of B cells. J Immunol (1979) 1.28
Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils. Exp Hematol (1977) 1.26
Oncogenic transformation of murine lymphoid cells by in vitro infection with Abelson leukemia virus. J Natl Cancer Inst (1975) 1.24
Clonal differences in response to T cell replacing factor (TRF) for IgM secretion and TRF receptors in a human B lymphoblast cell line. Eur J Immunol (1983) 1.18
Inhibitory effects of lectins and lymphocyte mitogens on murine lymphomas and myelomas. J Natl Cancer Inst (1973) 1.16
Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood (1988) 1.13
Immunostimulators induce granulocyte/macrophage colony-stimulating activity and block proliferation in a monocyte tumor cell line. J Exp Med (1977) 1.13
Monocyte-macrophage-derived acidic isoferritins: normal feedback regulators of granulocyte-macrophage progenitor cells in vitro. Blood (1982) 1.13
Independent control of immunoglobulin heavy and light chain expression in a murine pre-B-cell line. Nature (1981) 1.13
Expression of the macrophage specific colony-stimulating factor (CSF-1) during human monocytic differentiation. Biochem Biophys Res Commun (1986) 1.10
Lymphokine inducing "terminal differentiation" of the human monoblast leukemia line U937: a role for gamma interferon. Blood (1983) 1.06
Colony-stimulating factors and regulation of macrophage tumoricidal and microbicidal activities. Cell Immunol (1983) 1.05
Induction of IgG production in human B lymphoblastoid cell lines with normal human T cells. Nature (1978) 1.05
Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis. Blood (1980) 1.05
Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. Cancer Res (1985) 1.04
Cell-mediated lysis of tumor targets directed by murine monoclonal antibodies of IgM and all IgG isotypes. J Immunol (1983) 1.02
Differentiation of the IL-3-dependent NFS-60 cell line and adaption to growth in macrophage colony-stimulating factor. J Immunol (1990) 1.01
Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1. Cell Immunol (1987) 1.01
IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells. Eur J Immunol (1982) 0.99
Cell interactions influencing murine marrow megakaryocytes: nature of the potentiator cell in bone marrow. Blood (1981) 0.98
Induction of myeloid colony-stimulating activity in murine monocyte tumor cell lines by macrophage activators and in a T-cell line by concanavalin A. Cancer Res (1978) 0.98
Suppression of spleen natural killing activity induced by BCG. Clin Immunol Immunopathol (1980) 0.97
Human B cell-inducing factor(s) for production of IgM, IgG and IgA: independence from IL 2. J Immunol (1984) 0.95
In vitro immune response of human peripheral lymphocytes. IV. Specific induction of human suppressor T cells by an antiserum to the T leukemia cell line HSB. J Immunol (1979) 0.95
Interleukin 1 and poly(rI).poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells. Exp Hematol (1989) 0.94
Differential expression of M-CSF, G-CSF, and GM-CSF by human monocytes. J Leukoc Biol (1990) 0.93
Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by interleukin-1 and poly(rI).poly(rC). Blood (1988) 0.91
Molecular and biological properties of human macrophage growth factor, CSF-1. Cold Spring Harb Symp Quant Biol (1986) 0.91
Tumor promoter phorbol myristic acetate is a T-cell dependent inducer of immunoglobulin secretion in human lymphocytes. Clin Immunol Immunopathol (1982) 0.90
Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60. Cancer Res (1985) 0.88
A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody. J Immunol Methods (1997) 0.88
Lactoferrin, transferrin and acidic isoferritins: regulatory molecules with potential therapeutic value in leukemia. Blood Cells (1983) 0.87
Biological properties and molecular biology of the human macrophage growth factor, CSF-1. Immunobiology (1986) 0.87
Endocytosis by the mononuclear phagocyte system and autoimmune disease. Am J Med (1983) 0.87
Immunologic functions and in vitro activation of cultured macrophage tumor lines. Natl Cancer Inst Monogr (1978) 0.87
In vitro stimulation of phagocytosis in a macrophage cell line measured by a convenient radiolabeled latex bead assay. Cell Immunol (1979) 0.87
The role of humoral factors in the initiation of in vitro primary immune responses. IV. Are macrophages the adherent cell type required for cell cooperation. J Immunol (1974) 0.87
Induction of human immunoglobulin secretion. III. Inhibition of induction of IgG and IgA production in spleen but not peripheral blood cells by mitogenic antibody to IgM and IgD. Clin Immunol Immunopathol (1982) 0.86
Immunoglobulin synthesis in a cell-free system. Cold Spring Harb Symp Quant Biol (1967) 0.85
Tumor promoter phorbol myristic acetate stimulates immunoglobulin secretion correlated with growth cessation in human B lymphocyte cell lines. J Clin Invest (1981) 0.85
Induction of leukemia-associated inhibitory activity and bone marrow granulocyte-macrophage progenitor cell alterations during infection with Abelson virus. Cancer Res (1980) 0.84
The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Blood Cells (1987) 0.84
Antibody dependent cellular immunity in newborn mice. Nat New Biol (1973) 0.84
Human upper airway structural cell-derived cytokines support human peripheral blood monocyte survival: a potential mechanism for monocyte/macrophage accumulation in the tissue. Am J Respir Cell Mol Biol (1992) 0.83
Induction of human immunoglobulin secretion. II. T lymphocyte dependency and radiosensitivity of T-cell help for induction of B-cell differentiation by Staphylococcus aureus strain Cowan I. Cell Immunol (1982) 0.83
Independence of theta and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma. Biochem Biophys Res Commun (1973) 0.82
In vitro regulation of a mouse myelomonocytic leukemia line adapted to culture. Cancer Res (1977) 0.82
Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA). Leuk Res (1979) 0.82
IgM-IgG1, 2, 3 relationship during pregnancy. Nature (1972) 0.82
Suppression and restoration of cytotoxic T-cell activity during chemotherapy of a mouse T-cell lymphoma and a macrophage tumor. Cancer Res (1978) 0.82
Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells. Cell Immunol (1983) 0.81
Regulation of clonal B-lymphocyte proliferation by anti-immunoglobulin or anti-Ia antibodies. Cold Spring Harb Symp Quant Biol (1977) 0.81
Distinct signals for antibody-dependent and nonspecific killing of tumor targets mediated by macrophages. J Immunol (1982) 0.81
Biochemical characterization and purification of human B cell stimulatory factor (BSF). Eur J Immunol (1985) 0.80
Sensitivity to chemotherapeutic and immunomodulating agents of two mouse lymphomas and of a macrophage tumor. Cancer Res (1979) 0.80
Interleukin-6 is not involved in the interleukin-1-induced production of colony-stimulating factors by human bone marrow stromal cells and fibroblasts. Blood (1989) 0.80
Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines. Cancer Res (1981) 0.80
Augmentation of macrophage antibody-dependent killing of tumor targets by microtubule inhibitors. Cell Immunol (1982) 0.80